Venture Update: Monogram Orthopedics Closes $22 Million Reg A+ CF Round
Successful raises, in general, are a good sign.
For a pre-revenue company to close a successful first-raise is often times considered a sign of market validation.
Subsequent successful raises are generally good as well.
Monogram’s recent Reg A+ CF round closed at over $22 Million. This is uncanny.
Why do we like Monogram Orthopedics?
- Traction: This venture broke the “pre-revenue” mold last year
- Funding: A $22 Million CF round is beyond impressive
- Disruptor: The current surgical robotic leader has 87% of market share; that’s a long way to fall
- Total Addressable Market: Just knee replacements alone are a near $20 Billion market
Monogram Orthopedics also intends to go public; which is a good sign for future growth prospects.
Keep an eye on this one.
Blessings.

Zilos Capital Issues Short-Term Cautionary Guidance on Stocks as of August 16, 2021
Venture Update: Monogram Achieves $65 Million Valuation and Launches Series D Offering